Last Price
0.935
Today's Change
+0.10 (11.97%)
Day's Change
0.835 - 0.935
Trading Volume
38,175,265
Market Cap
678 Million
Shares Outstanding
726 Million
Avg Volume
6,157,049
Avg Price (50 Days)
0.78
Avg Price (200 Days)
1.18
PE Ratio
-1.20
EPS
-0.78
Earnings Announcement
18-Feb-2026
Previous Close
0.83
Open
0.84
Day's Range
0.835 - 0.935
Year Range
0.6625 - 1.86
Trading Volume
38,175,265
1 Day Change
11.98%
5 Day Change
15.43%
1 Month Change
16.88%
3 Month Change
-2.09%
6 Month Change
-30.22%
Ytd Change
-33.21%
1 Year Change
-42.28%
3 Year Change
-73.81%
5 Year Change
-69.04%
10 Year Change
-74.80%
Max Change
4.12%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
{uid}
{comment}
Just now